Protagonist Therapeutics (PTGX) investor relations material

Opening remarks and agenda

• The meeting was called to order by Matthew Gosling, EVP and Chief Legal and Business Officer, who introduced the board, executive officers, and external representatives in attendance.

• The meeting was held virtually, allowing stockholders to submit questions and vote online.

• The agenda included four proposals: election of directors, advisory vote on executive compensation, ratification of the auditor, and approval of the equity incentive plan.

Board and executive committee updates

• Board members present included Dr. Dinesh Patel (President & CEO), Harold Selick, Bryan Giraudo, Sarah O'Dowd, William Waddill, and Lewis Williams.

• Executive officers present were Dr. Patel, Asif Ali, and Arturo Molina.

Shareholder proposals

• Four proposals were presented: election of two Class I directors, advisory approval of executive compensation, ratification of Ernst & Young as auditor, and adoption of the 2026 equity incentive plan.